Therapeutic management of plaque psoriasis: the interest of anti-TNFalpha
Ortonne, J.P.
Annales de Dermatologie et de Venereologie 132(8-9 Pt 2: 4s6-4s9
2005
ISSN/ISBN: 0151-9638 PMID: 16335346 Document Number: 593229
Document emailed within 1 workday
Related Documents
Pariser, D.M.; Green, L.J.; Stein Gold, L.; Sugarman, J.L.; Lin, T.; Pillai, R. 2018: Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy Journal of Drugs in Dermatology: Jdd 17(7): 723-726Sobell, J.M.; Kalb, R.E.; Weinberg, J.M. 2009: Management of moderate to severe plaque psoriasis (part I): clinical update on antitumor necrosis factor agents Journal of Drugs in Dermatology: Jdd 8(2): 147-154
Sofen, H.; Hudson, C.P.; Cook-Bolden, F.E.; Preston, N.; Colón, L.E.; Colón, L.E.; Caveney, S.W.; Gottschalk, R.W. 2011: Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial Journal of Drugs in Dermatology: Jdd 10(8): 885-892
Lebwohl, M.; Menter, A.; Weiss, J.; Clark, S.D.; Flores, J.; Powers, J.; Balin, A.K.; Kempers, S.; Glinert, R.J.; Fleming, T.; Liu, Y.; Graeber, M.; Pariser, D.M. 2007: Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies Journal of Drugs in Dermatology: Jdd 6(4): 428-435
Hudson, C.P.; Kempers, S.; Menter, A.; Papp, K.; Smith, S.; Sofen, H.; Colón, L.E.; Johnson, L.A.; Gottschalk, R. 2011: An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis Cutis 88(4): 201-207
Kasiraman, V.; Atwan, A.A.; Durojaiye, O.C.; Kalavala, M.; Piguet, V. 2014: Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management Dermatology Online Journal 20(8)
Branten, A.J.W. 2008: Risk of infectious complications during anti-TNFalpha therapy Netherlands Journal of Medicine 66(2): 50-52
Gomollón, F.; López, S.G.ía. 2008: Treatment with anti-TNFalpha agents in Crohn's disease: what drug we have to use and when? Acta Gastroenterologica Latinoamericana 38(2): 133-145
Dekker, L.; Armbrust, W.; Rademaker, C.M.A.; Prakken, B.; Kuis, W.; Wulffraat, N.M. 2004: Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis Clinical and Experimental Rheumatology 22(2): 252-258
Bondeson, J. 1997: New therapeutic methods against rheumatoid arthritisp6. Antibodies against TNFalpha significant for the progress Lakartidningen 94(1-2): 42-45
D'Alessandria, C.; Malviya, G.; Viscido, A.; Aratari, A.; Maccioni, F.; Amato, A.; Scopinaro, F.; Caprilli, R.; Signore, A. 2007: Use of a 99mTc labeled anti-TNFalpha monoclonal antibody in Crohn's disease: in vitro and in vivo studies Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 51(4): 334-342
Brandt, H. 1989: Ditrastick combined with UVB. An alternative regimen for plaque psoriasis Acta Dermato-Venereologica. Supplementum 146: 102-103
Ahdout, J.; Mandel, H.; Chiu, M. 2008: Erythroderma in a patient taking acitretin for plaque psoriasis Journal of Drugs in Dermatology: Jdd 7(4): 391-394
Talamonti, M.; Galluzzo, M.; Chiricozzi, A.; Teoli, M.; Bavetta, M.; Costanzo, A.; Chimenti, S. 2012: Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome Journal of Drugs in Dermatology: Jdd 11(8): 1000-1002
Ardigò, M.; Giuliani, A.; de Felice, C.; Mastroianni, A.; Berardesca, E. 2008: Efficacy of adalimumab in plaque psoriasis: experience on 28 patients Journal of Drugs in Dermatology: Jdd 7(10): 935-939
Gooderham, M.; Posso-De Los Rios, C.J.; Rubio-Gomez, G.A.; Papp, K. 2015: Interleukin-17 (IL-17) inhibitors in the treatment of plaque psoriasis: a review Skin Therapy Letter 20(1): 1-5
Wu, J.J.; Valdecantos, W.C. 2017: Adalimumab in Chronic Plaque Psoriasis: a Clinical Guide Journal of Drugs in Dermatology: Jdd 16(8): 779-790
Zaghi, D.; Krueger, G.G.; Callis Duffin, K. 2012: Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis Journal of Drugs in Dermatology: Jdd 11(2): 160-167
Bartenjev, I.; Rogl Butina, M.; Potocnik, M. 2000: Subclinical microbial infection in patients with chronic plaque psoriasis Acta Dermato-Venereologica. Supplementum 2000(211): 17-18
Langley, R.G.; Gordon, K.B. 2007: Duration of remission of biologic agents for chronic plaque psoriasis Journal of Drugs in Dermatology: Jdd 6(12): 1205-1212